110 related articles for article (PubMed ID: 2068521)
1. [Serotonin and migraine. Hypothesis with pathogenic and pharmacological implications].
Montastruc JL
Rev Prat; 1991 May; 41(14):1281-4. PubMed ID: 2068521
[No Abstract] [Full Text] [Related]
2. [The world of serotonin and its receptors. Physiopathologic, clinical, and therapeutic aspects].
Marco Igual M
Med Clin (Barc); 1993 Jun; 101(4):144-53. PubMed ID: 8355545
[No Abstract] [Full Text] [Related]
3. [5-HT receptors. Significant target group in the treatment of migraine].
Dahlöf C; Edvinsson L
Lakartidningen; 1993 Feb; 90(7):569-74. PubMed ID: 8437466
[No Abstract] [Full Text] [Related]
4. Migraine management. New approaches focus on serotonin receptors.
DeRaps PK
Adv Nurse Pract; 1999 May; 7(5):51-5. PubMed ID: 10578735
[No Abstract] [Full Text] [Related]
5. [Migraine and serotonin: mechanisms and treatments].
Jacquy J
J Pharm Belg; 1996; 51(1):43-6. PubMed ID: 8882447
[No Abstract] [Full Text] [Related]
6. [Role of serotonin and other neuroactive molecules in the physiopathogenesis of migraine. Current hypotheses].
Hamon M; Bourgoin S
Pathol Biol (Paris); 2000 Sep; 48(7):619-29. PubMed ID: 11072640
[TBL] [Abstract][Full Text] [Related]
7. Developments in 5-hydroxytryptamine receptor pharmacology in migraine.
Peroutka SJ
Neurol Clin; 1990 Nov; 8(4):829-39. PubMed ID: 2259314
[TBL] [Abstract][Full Text] [Related]
8. [The role of agonists of serotonin receptor 5HT1B/D in pathogenesis and treatment of migraine attacks].
Stepień A
Pol Merkur Lekarski; 1999 Jun; 6(36):341-3. PubMed ID: 10481551
[TBL] [Abstract][Full Text] [Related]
9. Agonists and antagonists of 5-hydroxytryptamine on venomotor receptors.
Aellig WH
Adv Neurol; 1982; 33():321-4. PubMed ID: 7055012
[No Abstract] [Full Text] [Related]
10. Basic mechanisms of antimigraine drugs.
Fozard JR
Adv Neurol; 1982; 33():295-307. PubMed ID: 7034488
[No Abstract] [Full Text] [Related]
11. Studies in migraine.
Lance JW
Proc Aust Assoc Neurol; 1966; 4():81-4. PubMed ID: 5966206
[No Abstract] [Full Text] [Related]
12. The discovery of a new drug class for the acute treatment of migraine.
Humphrey PP
Headache; 2007 Apr; 47 Suppl 1():S10-9. PubMed ID: 17425704
[TBL] [Abstract][Full Text] [Related]
13. [The physiopathology of migraine].
Allain H; Schück S; Mauduit N; Saïag B; Pinel JF; Bentué-Ferrer D
Pathol Biol (Paris); 2000 Sep; 48(7):613-8. PubMed ID: 11072639
[TBL] [Abstract][Full Text] [Related]
14. [Basic mechanisms of the migraine physiopathology].
Martínez F; Castillo J; Noya M
Rev Neurol; 1995; 23(122):800-18. PubMed ID: 7497245
[No Abstract] [Full Text] [Related]
15. Current concepts of the pathophysiology of migraine.
Goadsby PJ
Neurol Clin; 1997 Feb; 15(1):27-42. PubMed ID: 9058395
[TBL] [Abstract][Full Text] [Related]
16. [Sumatriptan ++ in the treatment of migraine and cluster headache].
Láinez JM; Monzón MJ
Rev Neurol; 1995; 23 Suppl 2():S166-78. PubMed ID: 7497282
[No Abstract] [Full Text] [Related]
17. Effects on arterial receptors of ergot derivatives used in migraine.
Müller-Schweinitzer E; Fanchamps A
Adv Neurol; 1982; 33():343-56. PubMed ID: 6275676
[No Abstract] [Full Text] [Related]
18. [Physiopathology of the migraine crisis and its treatment with a 5-HT1-like agonist].
Arch Neurobiol (Madr); 1989; 52(5):254-6. PubMed ID: 2559670
[No Abstract] [Full Text] [Related]
19. Serotonin receptors and the acute attack of migraine.
Goadsby PJ
Clin Neurosci; 1998; 5(1):18-23. PubMed ID: 9523053
[TBL] [Abstract][Full Text] [Related]
20. New relief for migraine sufferers.
Chaplin S
Nurs J India; 1990 Jan; 81(1):29-30. PubMed ID: 2158086
[No Abstract] [Full Text] [Related]
[Next] [New Search]
